VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

• Status: RECRUITING
• Trial end date: 2026-07-01

Summary

The purpose of this study is to evaluate the safety,tolerability,pharmacokinetics and pharmacodynamics of VB19055 in the healthy Chinese population.

• Phase: PHASE1

Details

• Lead Sponsor: Zhejiang Yangli Pharmaceutical Technology Co., Ltd.